Intensive Short-Term Dynamic Psychotherapy (ISTDP) for Anxiety Diagnoses in a Primary Care Setting

Sponsor
Linnaeus University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05863637
Collaborator
Kalmar County Hospital (Other)
30
1
1
27
1.1

Study Details

Study Description

Brief Summary

Living with anxiety often means great suffering for the person affected. The trend points to a continued increase in anxiety problems in the population, especially in the 18-44 age group. Inadequate treatment of this condition can lead to long-term sick leave, isolation, exclusion and, in the worst case, to death. The treatment methods that are available in primary care today help some but far from all. Therefore, the investigators want to scientifically evaluate a shorter version of a proven emotion-focused psychotherapy in order to increase the treatment range for this patient group. The aim of this project is to, in a primary care setting, test and evaluate an intensive, emotion-focused short-term therapy, ISTDP (Intensive Short-Term Dynamic Psychotherapy) for patients with an anxiety diagnosis. The method is well-proven on patients with more severe mental conditions (personality disorders) with good results, but the treatment has only been tested to a limited extent on patients with anxiety symptoms. The investigators want to investigate the effectiveness of treating various anxiety states for primary care patients. The treatment is expected to provide an addition to today's methods, which overall will provide better treatment results for this, increasing in number, group of patients who often seek primary care.

Condition or Disease Intervention/Treatment Phase
  • Other: Intensive Short-Term Dynamic Psychotherapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Controlled study; participants (e.g. primary care patients with an anxiety disorder) will be recruited consecutively to the study, they will be put on a waiting-list for 3 months (= standard procedure) and thus be their own control person.Controlled study; participants (e.g. primary care patients with an anxiety disorder) will be recruited consecutively to the study, they will be put on a waiting-list for 3 months (= standard procedure) and thus be their own control person.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Anxiety Treatment in Primary Care: an Evaluation of Intensive Dynamic Short-term Therapy
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treated

Participants are their own controls when they are on the waiting list before treatment, and they will later be treated with the ISTDP.

Other: Intensive Short-Term Dynamic Psychotherapy
A dynamic and intensive psychotherapy with eight therapeutic sessions

Outcome Measures

Primary Outcome Measures

  1. Changes in the Generalized Anxiety Disorder-7 (GAD-7) scorings [Changes in scorings from baseline scorings to scorings after 9-10 months]

    Self-report measure measures

Secondary Outcome Measures

  1. Changes in the Perceived Health Questionnaire (PHQ-9) scorings [Changes in scorings from baseline scorings to scorings after 9-10 months]

    Self-report measure

  2. Changes in the Panic Disorder Severity Scale (PDSS) scorings [Changes in scorings from baseline scorings to scorings after 9-10 months]

    Self-report measure

  3. Changes in the Brunnsvikens Brief Quality of Life Inventory (BBQ) scorings [Changes in scorings from baseline scorings to scorings after 9-10 months]

    Self-report measure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary Care patients with primary anxiety diagnoses at a Health Care clinic in Sweden. Sufficient language competence in Swedish is required of the participants to understand, read, speak and write.
Exclusion Criteria:
  • Major reading-writing and learning difficulties, severe psychiatric problems such as psychosis, eating disorder, current major depression, recurrent depression, severe trauma, acute crisis reaction, exhaustion, acute risk of suicide (assessed according to the suicide scale), addiction.

  • Diagnosed specific phobia or obsessive-compulsive disorder that must be primarily treated with CBT. Concurrent psychological treatment, anxiety-relieving medication such as benzodiazepines, or recently started antidepressant treatment (< 3 months of treatment) are also exclusion criteria for participation in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Region Kalmar Kalmar Sweden 391 85

Sponsors and Collaborators

  • Linnaeus University
  • Kalmar County Hospital

Investigators

  • Study Director: Cecilia Fagerström, Professor, Director of the Research Board in Region Kalmar

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Suzanne Petersson, PhD, Linnaeus University
ClinicalTrials.gov Identifier:
NCT05863637
Other Study ID Numbers:
  • LinnaeusUSP
First Posted:
May 18, 2023
Last Update Posted:
May 18, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Suzanne Petersson, PhD, Linnaeus University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 18, 2023